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Dermal carotenoids are a feasible marker of the body antioxidative network and may reveal a moderate to severe imbalance of the
redox status, thereby providing indication of individual oxidative stress. In this work noninvasive Resonance Raman Spectroscopy
(RRS) measurements of skin carotenoids (skin carotenoid score (SCS)) were used to provide indications of individual oxidative
stress, each year for five years, in 71 breast cancer (BC) patients at high risk of recurrence. Patients’ SCS has been correlated with
parameters relevant to BC risk, waist circumference (WC), and body mass index (BMI), in the aim of monitoring the effect of
a dietary regimen intended to positively affect BC risk factors. The RRS methodological approach in BC patients appeared from
positive correlation between patients’ SCS and blood level of lycopene. The level of skin carotenoids was inversely correlated with
the patients’ WC and BMI. At the end of the 5 y observation BC patients exhibited a significant reduction of WC and BMI and
increase of SCS, when strictly adhering to the dietary regimen. In conclusion, noninvasive measurements of skin carotenoids can
(i) reveal an oxidative stress condition correlated with parameters of BC risk and (ii) monitor dietary-related variations in BC
patients.
1. Introduction
A proper redox balance is essential to control signalling
pathways governing cell functions, including those known
to influence cell proliferation [1–4]. Indeed critical varia-
tions of the redox homeostasis, not timely compensated by
endogenous systems, result in oxidative stress and concur
to dysfunction of several regulatory mechanisms leading to
cancer onset and development. Dietary plant constituents are
now acknowledged to play a significant role in this context.
The intense interaction of redox-active phytochemicals with
cells at different stages of cancer development is considered
essential to maintain the redox balance governing pathways
that control proliferation and evasion of cell-death, thus
contrasting both cancer onset and evolution [5, 6]. All this
has appeared strongly supported by epidemiological obser-
vations providing clear evidence that a dietary pattern such
as the traditional Mediterranean way of eating, including
large amounts of plant foods and derivatives, that is, fruits,
vegetables, olive oil, red wine, and legumes, may play a
primary role in promoting health and preventing onset and
progression of chronic and degenerative disorders including
various types of cancer [7–13].
Measuring the concentration of antioxidants in blood
samples may provide indication on the individual capacity
to maintain an optimal redox balance or conversely reveal
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an oxidative stress status. Molecular antioxidants in the body
work in concert and preserve each other; therefore the serum
level of each one, including carotenoids, is predictive of the
level of all others [14, 15] and is an expression of the individual
antioxidant status. An optical method, based on the Reso-
nance Raman Spectroscopy (RRS), has recently been devel-
oped for a noninvasivemeasurement of carotenoids in human
tissues. RRS is a laser spectroscopy based on the Raman
effect. When a low intensity laser monochromatic light inter-
acts with some molecules, these diffuse the light emitting a
new, higherwavelength,monochromatic light [16] that can be
revealed by a scanner converting Raman intensity in counts.
Because of their conjugated carbon backbone, carotenoids
possess characteristic vibrational/rotational energy levels
that make them particularly well suited for RRS, strongly
absorbing in the blue wavelength region and emitting in
the green one. RRS methodology has successfully been
exploited for the quantitative measurement of carotenoids
in human macula lutea, oral mucosa, and skin [17–20]. RRS
measurements of carotenoids in skin have been validated
by comparing with extraction and conventional high perfor-
mance liquid chromatography measurements of carotenoids
in skin samples [21]. Importantly, the level of dermal caro-
tenoids has appeared significantly correlated with the blood
carotenoid level [22–24]. In this context, the amount of
dermal carotenoids revealed by RRS can be considered a
marker of the individual antioxidative network, and its meas-
urement was applied to assess the body redox state and
eventually provide evidence of critical conditions in diseases.
Indeed, RRS measurements in humans have been inversely
correlated with urinary isoprostanes, known biomarkers for
oxidative stress [25].
RRS has been applied in our recent investigation aimed at
monitoring oxidative stress of beta-thalassemia patients and
correlating the amount of skin carotenoids with iron overload
[26].
In this work that comes as a complementary study of a
clinical trial starting in 2009 and ending in 2014, RRS mea-
surements of skin carotenoids have been carried out in breast
cancer (BC) operated patients, to research the oxidative
stress associated with this condition and monitor eventual
variations from a five-year-long treatment aimed at reducing
BC risk and recurrence by combining conventional therapies
with dietary intervention [27, 28]. The latter was based on a
traditional Mediterranean-style regimen, where a high daily
consumption of fruit and vegetables was fundamental and
was associated with a moderate physical activity. To substan-
tiate the RRS approach the level of dermal carotenoids has
been correlatedwithmarkers of BC risk (waist circumference,
WC, and body mass index (BMI)) [29], which finally pro-
vided evidence of the effectiveness of the RRS measurements
to monitor patient compliance and influence of the diet.
2. Patients and Methods
2.1. Subjects and Protocol. DIANA5 (Diet and Androgens-
5) is an Italian multicenter project of alimentary education,
aimed at preventing BC recurrence in patients surgically
treated for BC in the previous 5 years, who have not
developed distant metastasis or second primary BC and
are at high risk based on their hormonal and/or metabolic
milieu; that is, they exhibit one or more of high risk traits
(metabolic syndrome, oestrogen receptor negative tumor,
and high serum testosterone or insulin level) and associated
abnormal anthropometric parameters, WC and BMI [28].
Clinicopathological measurements, including blood level of
sex hormones, insulin, IGF-1, oestrogen receptors, glucose,
and lipid parameters, are determined as reported [30] to
serve as inclusion criteria in the project and are monitored
at baseline and yearly to detect eventual changes during the
time of intervention.
BC patients have been enrolled at the Department of
Oncology, ARNAS Ospedali Civico e Benfratelli G. Di Cris-
tina eM. Ascoli, Palermo, Italy, in January 2009, and followed
up to the end of 2014. Apart from conventional therapies,
patients were treated with dietary intervention. This was
based on a traditional Mediterranean diet, prescribed con-
sumption of seasonal fruits and vegetables (F/V, 5 servings
a day), unrefined grains, legumes, and olive oil, whereas sug-
ared drinks, alcoholic beverages, processed meat, and animal
fats were forbidden (detailed description of diet has been
reported in [30]). The intervention was intended to decrease
level of sex hormones, insulin and insulin growth factor 1
(IGF-1), and reduce risk factors associatedwith BCprognosis,
BMI andWC, [31, 32], additional breast cancer events, and the
risk ofmetastasis [11].Moderate physical activity was also rec-
ommended.All patients received theWCRF-based guidelines
for cancer prevention (see the list below) and were invited to
participate in dedicated kitchen courses and physical exercise
sessions; in addition, they filled in a questionnaire reporting
on their own life- and dietary-style. The patients were
followed up for vital status and BC related events, including
BC-specific mortality, distant metastasis, local recurrences,
and contro-lateral BC, which were obtained by self-reporting
every six months throughout the study.
The following list is based on the World Cancer Research
Fund (WCRF) and American Institute of Cancer Research
(AICR).
WCRF/AICR 2007 Recommendation
(i) Be as lean as possible within the normal range of body
weight.
(ii) Be physically active as part of everyday life.
(iii) Limit consumption of energy-dense food and avoid
sugary drinks.
(iv) Eat mostly food of plant origin, with a variety of
nonstarchy vegetables and fruit every day and unpro-
cessed cereals and/or pulses within every meal.
(v) Limit intake of red meat and avoid processed meat.
(vi) Limit alcoholic drinks.
(vii) Limit consumption of salt and avoid mouldy cereals
or pulses.
(viii) Aim to meet nutritional needs through diet alone.
(ix) Children to be breastfed by their mothers for at least
six months.
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(x) Cancer survivors follow the recommendation for can-
cer prevention.
2.2. The Carotenoid Study. In 2009, a number of BC patients
(𝑛 = 71) were randomly recruited among the patients
enrolled at the Centre of Palermo, aged 36 to 74, nonsmokers,
accepted with informed consent, and who were to be exam-
ined for body redox status, andwere invited for RRSmeasure-
ment of skin carotenoids (skin carotenoid score (SCS)), as an
index of oxidative stress. Each patient contributed a duplicate
measurement at the baseline and then each year, with a 12-
month interval, until 2014. Anthropometric measurements,
weight (kg), andWC (cm) were collected each time, and BMI
(body mass in kilograms/square of height in meters, kg/m2)
was measured as reported [29]. Our observation ended in
June 2014 and all patients terminated the study.
Healthy women (HW) were interviewed and examined
for skin carotenoids in 2009. The mean SCS from a number
of nonsmokingHW (𝑛 = 120), reporting being used to eating
high amounts of F/V (5 servings a day), aged 38 to 70, BMI
between 20.5 and 31 (mean 24.5 ± 3), and WC between 62
and 100 (mean 80.6 ± 6.3), was taken as the reference SCS
throughout our study (HW-SCS, 39,210 ± 9,400; min HW-
SCS 20,000; max HW-SCS 75,000).
2.3. Measurement of Carotenoids in Skin. A portable Raman
spectroscope, Pharmanex® BioPhotonic Scanner S2 (NuSkin,
Provo, Utah, USA), designed to monitor carotenoids in the
0.1mm stratum corneum of the skin of the hand, has been
used for the measurements. A low intensity 471.3–473 nm
radiation from light emitting diodes interacts with the skin
carotenoids. The scattered light is detected at 507.8–509.8 nm
by the scanner that converts the Raman intensity in counts
(skin carotenoid score (SCS)). A computer then transforms
the scanner signals in a colored scale going from red (poor
carotenoid score, <19,000) to dark blue (high carotenoid
score,>50,000). SCS can be converted to laboratorymeasure-
ments using the equation [𝑌 = 12703 × 𝑋 + 5891.7], where
“𝑌” is the SCS value and “𝑋” is the carotenoid concentration
expressed as micrograms/mL of serum.
2.4. Measurement of Lycopene. Blood lycopene of patients
who submitted themselves to skin carotenoid evaluation was
measured. Duplicate measurements from the same sample
were carried out. Lycopene was extracted from 500𝜇L serum
samples, diluted 1 : 2 with 0.15mM NaCl, with 1 volume of
methanol and 3 volumes of hexane: diethyl ether (l : l,
vol : vol). The extracts were then dried under nitrogen, resus-
pended with a mixture of acetonitri1e :methanol : tetrahy-
drofurane (58.5 : 35 : 6.5, vol : vol : vol), and analyzed with
the same solvent [33] by a HPLC Supelco Supelcosil LC-
18 column (0.46 × 25 cm) (Bellefonte, PA), at a flow rate of
2.5mLmin−1. Under these conditions lycopene eluted at 8.2
minutes. Revelation was at 450 nm.
2.5. Statistical Analysis. BMI, WC, and SCS are expressed as
means and standard deviation (SD) of the patients’ values.
Differences in SCS among groups of fruit and vegetable
intakes andBMIwere tested by analysis of variance (ANOVA)
and Bonferroni post hoc tests, with 𝑝 < 0.05 being taken
as significant. Pearson’s correlations were used to determine
the relationship between SCS and BMI or WC. All statistical
analyses were done using GRAPHPAD PRISM v5 (GraphPad
Software, San Diego, California, USA), SYSTAT version 10.0
(SPSS, Chicago, IL, USA), and Microsoft Excel.
3. Results and Discussion
Cancer control can be achieved by decreasing the rate of
oxidative stress and enhancing antioxidant defense mecha-
nisms. In this context the role of F/V and dietary redox-
active phytochemicals in reducing the risk of cancer includ-
ing BC [11, 27, 30, 34], by regulating antioxidant defense
mechanisms and redox signaling, has long been described
[35–37]. Dermal carotenoids can be regarded as biomarkers
of the body antioxidant status [16, 38], as well as of fruit
and vegetable intake in nutritional studies [21]. On this basis,
dermal carotenoids have been monitored for five years in
71 BC operated patients at high risk of recurrence, to assess
oxidative stress status and influence of dietary treatment
based on high daily consumption of fruit and vegetables.
3.1. Dermal Carotenoids Are Correlated with Plasma Lycopene
in BC Patients. Relatively high concentrations of carotenoids
accumulate in human skin. The RRS-based measurement of
dermal carotenoids has been validated in healthy adults by
pairing blood and skin levels of carotenoids [21]. Feasibility of
the RRS approach to measure skin carotenoids as a reflection
of their plasma concentration was at first explored in BC
patients. Since lycopene is the major carotenoid in the skin
[17, 18], the individual correlation between SCS and the
plasma level of lycopenewas examined. Figure 1(a), reporting
data at the baseline in 2009, shows a net positive correlation,
thus validating the use of this spectroscopic method to
evaluate the body carotenoid level even in BC patients. The
positive correlation was also confirmed at the end of the
observation in 2014 (Figure 1(b)).
3.2. Variations of Dermal Carotenoids in BC Patients during
the 5 y Dietary Intervention. To the best of our knowl-
edge, only a few trials investigated skin carotenoid response
by Raman Spectroscopy to controlled diets [39] including
increase of fruit and vegetables [24, 40], and none was
carried out on cancer patients. BCpatients underwent dermal
carotenoids measurements with a 12-month interval to assess
the evolution of the oxidative stress status during the 5 years
of observation. SCS (means ± SD of the values recorded at
the end of each year) are reported in Figure 2(a). The SCS
increased significantly during the first and second year of
observation; thereafter only a nonsignificant positive trend
was observed (Figure 2). However, while the SCS of patients
at starting (28,580 ± 10,060, 𝑛 = 71) was approximately 28%
lower than the reference value of healthy women (HW-SCS =
39,210 ± 9,400, 𝑛 = 120) (𝑝 < 0.001, Student’s 𝑡-test),
no significant difference was found at the end of observation
(mean SCS 38,590 ± 9,920, 𝑛 = 71) (𝑝 = 0.67), indicating
improvement of the antioxidant status. On the other hand,
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Figure 1: Correlation between plasma lycopene and skin carotenoid score (SCS) in BC patients (𝑛 = 71): (a) before (𝑟 = 0.450; 𝑝 < 0.0001)
and (b) after (𝑟 = 0.559; 𝑝 < 0.0001) five years of dietary intervention. SCS and lycopene values are the mean of duplicate measurements
(𝑛 = 71; 𝑝 < 0.0001).
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Figure 2: Skin carotenoid score (SCS) of BC patients (𝑛 = 71) during the five years of dietary intervention. (a) Data are the mean ± SD of
measurements carried out in duplicate on the patients once a year. Values of columns labelled with different letters are statistically different
(𝑝 < 0.05, Anova one way followed by Bonferroni’s multiple comparison test). (b) Values of single patients at starting (2009) observation and
at the end (2014) of observation.
a very high interindividual variability in the SCS progress
and evolution was evident when the values of each patient in
2009 (𝑛 = 71) were judged against the relevantmeasurements
5 years later (Figure 2(b)): the increase varied from 101% to
1300% (𝑛 = 56); 3 of the patients did not change their level
of carotenoids, and 12 of them exhibited a decrease varying
between 3% and 30%. It may be interesting to mention
that the major percent increments were observed in patients
showing the highest redox imbalance at starting (𝑛 = 9,
SCS 3,000 to 15,000), whereas the patients exhibiting a
decrease of the carotenoid score were in a medium-high SCS
range (30,000 to 40,000). A number of reasons including
adiposity [16] and/or concomitant therapies may account
for the differences between the individual response to the
intervention, including a higher or lower adherence of the
patients to the dietary rules.
3.3. Variations of BMI and WC in BC Patients before and
after the 5 yDietary Intervention. The importance of BMI and
WC as prognostic factors in BC is well documented [31, 32];
then measurements of these parameters can help to follow
the evolution in the status of BC patients.TheMediterranean
dietary pattern is intended to reduce risk factors for breast
cancer and then affect positively BMI and WC [41]. This was
also observed in the patients under our observation. Figure 3
compares themean values of BMI andWC in patients in 2009
and at the end of the intervention in 2014. Both BMI andWC
were significantly reduced.
3.4. Correlation between Oxidative Stress and BC Risk Factors.
Since both oxidative stress and anthropometric parameters,
either WC or BMI, are associated with the BC pathology and
changed positively at the end of the trial, we hypothesized that
a correlation existed between these factors. The correlation
between SCS and either BMI or BC is shown in Figure 4.Only
a negative trend existed at starting (Figures 4(a) and 4(d)),
whereas a significant inverse correlation was observed two
years later (Figures 4(b) and 4(e)) and at the end of the inter-
vention in 2014, with an even greater significance (Figures
4(c) and 4(f)), indicating that a higher number of patients had
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Figure 3: Body mass index (BMI) (a) and waist circumference (WC) (b) of BC patients at starting (2009) and at the end (2014) of five years
of dietary intervention. Values are the mean ± SD of measurements carried out on all patients (𝑛 = 71). With respect to the relevant values in
2009, values are significant with ∗𝑝 < 0.0001 or ∗∗𝑝 = 0.0072 (paired 𝑡-test).
increased SCS, that is, achieved a better control of redox status
and reduced oxidative stress, with concomitant reduction of
BMI and WC. The poor correlation at starting may be an
expression of particular additional factors besides the BC
status, concurring to an oxidative stress high or very high
(e.g., some of the patients had undergone recent surgery and
chemotherapy (𝑛 = 4) and some had been smoker before
starting the trial (𝑛 = 8), which prevents a clear correlation of
SCS with BMI and/or BC). The inverse correlation observed
after an equilibrium condition was getting on is further
indicative of the great importance of a good redox balance
and lowWC and BMI in the BC pathology. Indeed, a negative
correlation between SCS and BMI andWCwas also observed
in HW (Figures 4(d) and 4(h)), in accordance with data
reported for healthy adults [21, 42].
3.5. Oxidative Stress and Compliance with Dietary Rules.
Whether and/or to what extent compliance with the dietary
intervention was involved in improving the antioxidant
balance was evaluated. At the end of the intervention in 2014,
all questionnaires filled in by patients, yearly reporting on
their own life- and dietary-style, were examined. Patients
were then divided into two groups according to whether they
reported to have strictly adhered to the dietary rules and
constantly consumed five F/V servings per day (𝑛 = 39) or
whether they had not been steady in observing constantly
the dietetic pattern (𝑛 = 32). The SCS values measured for
both groups at the end of observation were then compared
with values at starting. The data as means ± SD are reported
in Figure 5. At the end of the study, SCS was remarkably
lower for the patients that had less than five servings per day,
with respect to patients having five, although both groups
of patients did not differ significantly at starting (Figure 5).
While showing that the better was the compliance of patients
with the dietetic pattern, the higher was the body level of
antioxidants; these data suggested that diet had a major role
in ameliorating their body redox balance and then positively
affected oxidative stress.
3.6. Follow-Up. Our observation stopped in June 2014. The
patients were followed up for vital status and occurrence of
new BC events by clinicians. We were informed that, within
December 2014, one patient out of 71 who underwent the SCS
measurements passed away and five patients had recurrence.
Wemay also report that 43 of all patients recruited at the cen-
tre in Palermo (𝑛 = 391) had recurrence, whereas 13 passed
away. A thorough knowledge and analysis of data gathered
from all Italian centres participating in the DIANA5 project
are necessary to determine to what extent the dietetic pattern
and lifestyle adopted may affect the outcome of BC patients.
4. Conclusions
The development of biomarkers for oxidative stress as a diag-
nostic, prognostic, and therapeutic approach has attracted
a lot of interest recently. This was the only study designed
to evaluate the antioxidant balance as an index of oxidative
stress in BC operated patients at high risk of recurrence,
by RRS measurement of dermal carotenoids, and monitor
the skin carotenoid response to a 5 y long dietary inter-
vention intended to decrease BC risk factors. The treatment
indeed caused a decrease of BMI and WC, while the dermal
carotenoid level appeared inversely correlatedwith both these
parameters. To the best of our knowledge, skin carotenoids
have never been correlated to risk factors for cancer. The
observed correlation between SCS and BMI and WC, two
prognostic factors for breast cancer, appears to reflect the
importance of all these parameters on this condition and
allows SCS to be considered as a reliable additional tool to
monitor at-risk individuals and/or effectiveness of interven-
tions. In addition, our findings confirm the effectiveness of
the RRS methodology to reveal body redox state even in
patients whose antioxidant status is remarkably altered [26].
Breast cancer (BC) is one of the most common in
women, with over 400,000 deaths worldwide every year
[43]. Surgery, radiotherapy, chemotherapy, and/or hormone
therapy are shown to be only partially effective in reducing
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Figure 4: Correlation between SCS and either BMI (a–c) or WC (e–g) in BC patients (𝑛 = 71) at starting and during the course of five years
of dietary intervention and in healthy women (𝑛 = 120, (d) and (h)). Each SCS value is the mean of duplicate measurements. Patients: (a)
(𝑟 = −0.118; 𝑝 = 0.326); (b) (𝑟 = −0.259; 𝑝 = 0.028); (c) (𝑟 = −0.351; 𝑝 = 0.0027); (e) (𝑟 = −0.099; 𝑝 = 0.408); (f) (𝑟 = −0.267; 𝑝 = 0.023);
(g) (𝑟 = −0.265; 𝑝 = 0.025); healthy women: (d) (𝑟 = −0.276; 𝑝 < 0.0022); (h) (𝑟 = −0.33; 𝑝 < 0.0002).
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Figure 5: Variations of SCS after five years of dietary intervention
in BC patients that had consumed less than five (A, 𝑛 = 39) or five
(B, 𝑛 = 32) F/V servings per day. The values are the mean ± SD of
duplicate measurements at starting (white bar) and at the end (grey
bar) of observation. ($) with respect to the relevant value in 2009,
significant with 𝑝 < 0.0001 (paired 𝑡-test). (∗) with respect to A in
2014, significant with 𝑝 < 0.0001 (unpaired 𝑡-test).
morbidity, which emphasizes the importance of prevention.
To this aim lifestyle factors, including diet, are considered
fundamental [7–13]. Our work highlights the importance of a
firmadhesion to a recommendeddietary pattern and suggests
a useful tool to help the patients’ motivation. The SCS value
has appeared an objective tool to evaluate the effectiveness
of the dietary intervention in BC patients. Such a simple and
noninvasive measurement may be useful to improve patient
awareness of the importance of adhesion to healthy lifestyle
and alimentary regimen to positively affect BC risk factors.
In our experience these measurements allowed each patient
to appraise the effectiveness of her own strains, helping her
to understand the accuracy of the diet performed or whether
corrections had to be made.
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